Asset Details
Do you wish to reserve the book?
Baicalin attenuates aflatoxin B 1 -induced hepatotoxicity via suppressing c-Jun-N-terminal kinase-mediated cell apoptosis
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Baicalin attenuates aflatoxin B 1 -induced hepatotoxicity via suppressing c-Jun-N-terminal kinase-mediated cell apoptosis
Do you wish to request the book?
Baicalin attenuates aflatoxin B 1 -induced hepatotoxicity via suppressing c-Jun-N-terminal kinase-mediated cell apoptosis
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Baicalin attenuates aflatoxin B 1 -induced hepatotoxicity via suppressing c-Jun-N-terminal kinase-mediated cell apoptosis
2024
Overview
Aflatoxin B
(AFB
) is classified as a Class I carcinogen and common pollutant in human and animal food products. Prolonged exposure to AFB
can induce hepatocyte apoptosis and lead to hepatotoxicity. Therefore, preventing AFB
-induced hepatotoxicity remains a critical issue and is of great significance. Baicalin, a polyphenolic compound derived from Scutellaria baicalensis Georgi, has a variety of pharmacodynamic activities, such as antiapoptotic and anticancer activities. This study systematically investigated the alleviating effect of baicalin on AFB
-induced hepatotoxicity from the perspective of apoptosis and explored the possible molecular mechanism. In the normal human liver cell line L02, baicalin treatment significantly inhibited AFB
-induced c-Jun-N-terminal Kinase (JNK) activation and cell apoptosis. In addition, the in vitro mechanism study demonstrated that baicalin alleviates AFB
-induced hepatocyte apoptosis through suppressing the translocation of phosphorylated JNK to the nucleus and decreasing the phosphorylated c-Jun/c-Jun ratio and the Bax/Bcl2 ratio. Molecular docking and drug affinity responsive target stability assays demonstrated that baicalin has the potential to target JNK. This study provides a basis for the therapeutic effect of baicalin on hepatocyte apoptosis caused by AFB
, indicating that the development of baicalin and JNK pathway inhibitors has broad application prospects in the prevention of hepatotoxicity, especially hepatocyte apoptosis.
